Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.
Garscha U, Romp E, Pace S, Rossi A, Temml V, Schuster D, König S, Gerstmeier J, Liening S, Werner M, Atze H, Wittmann S, Weinigel C, Rummler S, Scriba GK, Sautebin L, Werz O.
Garscha U, et al. Among authors: rossi a.
Sci Rep. 2017 Aug 24;7(1):9398. doi: 10.1038/s41598-017-09795-w.
Sci Rep. 2017.
PMID: 28839250
Free PMC article.